Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-16

Clinical Trial Update: Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease

View source ↗

Summary

Clinical trial update on the antiplatelet effects of evolocumab in patients with peripheral arterial disease; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evolocumab (evolocumab)

Snippet

Sponsor: Inova Health Care Services | Conditions: Peripheral Arterial Disease | Status: TERMINATED | Results posted: 2024-02-16